• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Seeing the Same Old Patterns Ahead of Fed News

Buyers expect a dovish Fed and are still trying to put money to work.
By JAMES "REV SHARK" DEPORRE
Sep 19, 2016 | 10:55 AM EDT
Stocks quotes in this article: SRPT, GBT, RETA, GLPG, SUPN, NERV, AIRG, TPIC, LNTH, AAPL, FB, BABA

With the Fed rate announcement coming up on Wednesday, it is very easy to overthink what this market is going to do. The bears are still hoping that the announcement will trigger the long-awaited correction, but this morning we still see positive action in anticipation of a dovish central bank. A bounce in oil is also helping a bit, but primarily the buyers are unconcerned about the Fed and still trying to put money to work.

All the talk about terrorism is having no impact on this market at all. It simply doesn't generate a response any longer. If the indices were down, you would see some linkage to the headlines, but this is all about the Fed, right now.

Approval of Sarepta Therapeutics' (SRPT) lead drug caused the whole biotechnology sector to heat up, as there is now an indication that maybe the FDA dynamics are shifting -- and that may lead to faster approvals in other situations. SRPT has been a battleground stock for four years, and the resolution today is helping other stocks in the biotech group.

Some of the key biotech names on my screens include Global Blood Therapeutics  (GBT) , Reata Pharmaceuticals (RETA) , Galapagos (GLPG) , Supernus Pharmaceuticals (SUPN) and Minerva Neurosciences (NERV) .

Recent favorites Airgain (AIRG) and TPI Composites (TPIC) continue to trade strongly. AIRG is reporting earnings in the morning and I'm inclined to cut it back a bit before the news. Lantheus (LNTH) continues to bounce higher after pricing a secondary, but I'm not adding too much new inventory, right now.

Some of the large-cap names, such as Action Alerts PLUS holdings Apple (AAPL)  and Facebook (FB) , and Alibaba (BABA) , are slowing after good runs.

The market obviously still has bids, but momentum may cool as we await the Fed news. I don't see any reason to be bearish, but I won't be surprised to see some profit taking in individual names that have been a bit overheated lately.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long GBT, FB, AIRG, TIPC and LNTH, although positions may change at any time.

TAGS: Investing | U.S. Equity | Healthcare | Technology | Markets | Stocks

More from Healthcare

Johnson & Johnson Appears to Be Running Out of Steam

Bruce Kamich
Jun 22, 2022 8:25 AM EDT

The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.

Anthem's Long-Term Uptrend Is Losing Its Vigor

Bruce Kamich
Jun 22, 2022 7:40 AM EDT

The technical signals of the health benefits provider are weakening.

Here Are 2 Prudent Healthcare Trades

Bret Jensen
Jun 17, 2022 11:30 AM EDT

The country might be heading into recession, but folks still need to get their medicine, good times or bad.

Here's the Level to Zero In on for UnitedHealth Group

Bruce Kamich
Jun 13, 2022 7:29 AM EDT

Shares of the diversified healthcare company have held up fairly well despite the decline in the broader market but soon could be put to the test.

3 Dividend-Paying Healthcare Stocks That Age Well

Bob Ciura
Jun 5, 2022 12:30 PM EDT

Within the next 15 years, people 65 or older are expected outnumber those under 18, for the first time in U.S. history.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • 12:08 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    As a Portfolio Name Agrees to a Merger, Here's Our...
  • 10:44 AM EDT PAUL PRICE

    My Very Best Pick for the Next 12 Months

    American Woodmark . It rarely gets better than th...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login